Norman Putzki
Natalizumab in the treatment of multiple sclerosis
Putzki N. Natalizumab in the treatment of multiple sclerosis. Therapeutic Adv Neurol 2009; 2:115-128.
May 1, 2009Natalizumab in the treatment of multiple sclerosis
May 1, 2009Therapeutic Adv Neurol 2009; 2:115-128
Putzki Norman
First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5T and 7T
Kollia K, Maderwald S, Putzki N, Schlamann M, Theysohn J, Kraff O, Ladd M, Forsting M, Wanke I. First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5T and 7T. AJNR. American journal of neuroradiology 2009; 30:699-702.
Apr 1, 2009First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5T and 7T
Apr 1, 2009AJNR. American journal of neuroradiology 2009; 30:699-702
Kollia K, Maderwald S, Putzki Norman, Schlamann M, Theysohn J M, Kraff O, Ladd M E, Forsting M, Wanke I
Innovative orale Therapien der schubförmigen MS
Putzki N. Innovative orale Therapien der schubförmigen MS. Schweizer Zeitschrift für Psychiatrie & Neurologie 2009; 1:32-39.
Mar 13, 2009Innovative orale Therapien der schubförmigen MS
Mar 13, 2009Schweizer Zeitschrift für Psychiatrie & Neurologie 2009; 1:32-39
Putzki Norman
Natalizumab is effective as second line therapy in the treatment of relapsing remitting multiple sclerosis
Putzki N, Kollia K, Woods S, Igwe E, Diener H, Limmroth V. Natalizumab is effective as second line therapy in the treatment of relapsing remitting multiple sclerosis. European journal of neurology : the official journal of the European Federation of Neurological Societies 2009; 16:424-6.
Mar 1, 2009Natalizumab is effective as second line therapy in the treatment of relapsing remitting multiple sclerosis
Mar 1, 2009European journal of neurology : the official journal of the European Federation of Neurological Societies 2009; 16:424-6
Putzki Norman, Kollia K, Woods S, Igwe E, Diener H C, Limmroth V
Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis
Tettenborn B, Putzki N, Pfriem A, Limmroth V, Yaldizli O, Diener H, Katsarava Z. Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis. Eur J Neurol 2009; 16(2):262-7.
Feb 7, 2009Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis
Feb 7, 2009Eur J Neurol 2009; 16(2):262-7
Tettenborn Barbara, Putzki Norman, Pfriem A, Limmroth V, Yaldizli Oezguer, Diener HC, Katsarava Z
Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis
Putzki N, Pfriem A, Limmroth V, Yaldizli O, Tettenborn B, Diener H, Katsarava Z. Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis. European journal of neurology : the official journal of the European Federation of Neurological Societies 2009; 16:262-7.
Feb 1, 2009Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis
Feb 1, 2009European journal of neurology : the official journal of the European Federation of Neurological Societies 2009; 16:262-7
Putzki Norman, Pfriem A, Limmroth V, Yaldizli O, Tettenborn B, Diener H C, Katsarava Z
Mitoxantrone does not restore the impaired suppressive function of natural regulatory T cells in patients suffering from multiple sclerosis. A longitudinal ex vivo and in vitro study
Putzki N, Kumar M, Kreuzfelder E, Grosse-Wilde H, Diener H, Limmroth V. Mitoxantrone does not restore the impaired suppressive function of natural regulatory T cells in patients suffering from multiple sclerosis. A longitudinal ex vivo and in vitro study. European neurology 2009; 61:27-32.
Jan 1, 2009Mitoxantrone does not restore the impaired suppressive function of natural regulatory T cells in patients suffering from multiple sclerosis. A longitudinal ex vivo and in vitro study
Jan 1, 2009European neurology 2009; 61:27-32
Putzki Norman, Kumar Manoj, Kreuzfelder Ernst, Grosse-Wilde Hans, Diener H C, Limmroth Volker
Treatment of Multiple Sclerosis
Putzki N, Hartung H. Treatment of Multiple Sclerosis. Bremen: Unimed, 2009. ISBN 978-3-8374-2093-7.
Jan 1, 2009Treatment of Multiple Sclerosis
Jan 1, 2009Unimed, ISBN 978-3-8374-2093-7
Putzki Norman, Hartung Hans Peter
Fatigue bei therapierten und untherapierten Patienten mit schubförmiger und sekundär progredienter Multipler Sklerose
Putzki N, Yaldizli O, Tettenborn B. Fatigue bei therapierten und untherapierten Patienten mit schubförmiger und sekundär progredienter Multipler Sklerose. Aktuelle Neurologie 2008; 9
Sep 24, 2008Fatigue bei therapierten und untherapierten Patienten mit schubförmiger und sekundär progredienter Multipler Sklerose
Sep 24, 2008Aktuelle Neurologie 2008; 9
Putzki Norman, Yaldizli Ozgür, Tettenborn Barbara
Fatigue bei therapierten und untherapierten Patienten mit schubförmiger und sekundär progredienter Multipler Sklerose
Tettenborn B, Putzki N, Yaldizli O. Fatigue bei therapierten und untherapierten Patienten mit schubförmiger und sekundär progredienter Multipler Sklerose. Aktuelle Neurologie 2008; 9:9.
Sep 7, 2008Fatigue bei therapierten und untherapierten Patienten mit schubförmiger und sekundär progredienter Multipler Sklerose
Sep 7, 2008Aktuelle Neurologie 2008; 9:9
Tettenborn Barbara, Putzki Norman, Yaldizli Oezguer
Increased basal-ganglia activation performing a non-dystonia-related task in focal dystonia
Obermann M, Diener H, Gizewski E, Vollmer-Haase J, Putzki N, Buhl A, Tumczak F, Lachenmayer M, Konczak J, de Greiff A, Yaldizli O, Maschke M. Increased basal-ganglia activation performing a non-dystonia-related task in focal dystonia. European journal of neurology : the official journal of the European Federation of Neurological Societies 2008; 15:831-8.
Aug 1, 2008Increased basal-ganglia activation performing a non-dystonia-related task in focal dystonia
Aug 1, 2008European journal of neurology : the official journal of the European Federation of Neurological Societies 2008; 15:831-8
Obermann M, Diener H-C, Gizewski E R, Vollmer-Haase J, Putzki Norman, Buhl A R, Tumczak F, Lachenmayer M L, Konczak J, de Greiff A, Yaldizli O, Maschke M
Habituation of the auditory startle response in cervical dystonia and Parkinson's disease
Putzki N, Graf K, Stude P, Diener H, Maschke M. Habituation of the auditory startle response in cervical dystonia and Parkinson's disease. European neurology 2008; 59:172-8.
Jan 1, 2008Habituation of the auditory startle response in cervical dystonia and Parkinson's disease
Jan 1, 2008European neurology 2008; 59:172-8
Putzki Norman, Graf Karoline, Stude Philipp, Diener Hans-Christoph, Maschke Matthias
Prevalence and severity of multiple-sclerosis-associated fatigue in treated and untreated patients
Putzki N, Katsarava Z, Vago S, Diener H, Limmroth V. Prevalence and severity of multiple-sclerosis-associated fatigue in treated and untreated patients. European neurology 2008; 59:136-42.
Jan 1, 2008Prevalence and severity of multiple-sclerosis-associated fatigue in treated and untreated patients
Jan 1, 2008European neurology 2008; 59:136-42
Putzki Norman, Katsarava Zaza, Vago Susanne, Diener H C, Limmroth Volker
Relapsing neuromyelitis optica responsive to glatiramer acetate treatment
Gartzen K, Limmroth V, Putzki N. Relapsing neuromyelitis optica responsive to glatiramer acetate treatment. European journal of neurology : the official journal of the European Federation of Neurological Societies 2007; 14:e12-3.
Jun 1, 2007Relapsing neuromyelitis optica responsive to glatiramer acetate treatment
Jun 1, 2007European journal of neurology : the official journal of the European Federation of Neurological Societies 2007; 14:e12-3
Gartzen K, Limmroth V, Putzki Norman
QUASIMS: eine deutschlandweite Beobachtungsstudie der Interferon-Beta-Präparate zur Therapie der schubförmigen multiplen Sklerose
Putzki N, Limmroth V. QUASIMS: eine deutschlandweite Beobachtungsstudie der Interferon-Beta-Präparate zur Therapie der schubförmigen multiplen Sklerose. Aktuelle Neurologie 2007; 01
Jan 11, 2007QUASIMS: eine deutschlandweite Beobachtungsstudie der Interferon-Beta-Präparate zur Therapie der schubförmigen multiplen Sklerose
Jan 11, 2007Aktuelle Neurologie 2007; 01
Putzki Norman, Limmroth Volker
Quality Assessment in Multiple Sclerosis Therapy (QUASIMS): a comparison of interferon beta therapies for relapsing-remitting multiple sclerosis
Limmroth V, Wernsdörfer C, Kalski G, Putzki N, Hasford J, Brosig A, Meier U, Viehöver A, Obhof W, Elias W, Haller P, Japp G, Koehler J, Zettl U, Malessa R, QUASIMS Study Group. Quality Assessment in Multiple Sclerosis Therapy (QUASIMS): a comparison of interferon beta therapies for relapsing-remitting multiple sclerosis. Journal of neurology 2007; 254:67-77.
Jan 1, 2007Quality Assessment in Multiple Sclerosis Therapy (QUASIMS): a comparison of interferon beta therapies for relapsing-remitting multiple sclerosis
Jan 1, 2007Journal of neurology 2007; 254:67-77
Limmroth Volker, Wernsdörfer Colin, Kalski Gabriele, Putzki Norman, Hasford Joerg, Brosig Arne, Meier Uwe, Viehöver Andrea, Obhof Winfried, Elias Wolfgang, Haller Peter, Japp Gudrun, Koehler Jürgen, Zettl Uwe Klaus, Malessa Rolf, QUASIMS Study Group
1000 Fragen zur Facharztprüfung Neurologie (1000 questions to prepare medical board examination in neurology)
Putzki N. 1000 Fragen zur Facharztprüfung Neurologie (1000 questions to prepare medical board examination in neurology). Stuttgart: Thieme, 2007.
Jan 1, 20071000 Fragen zur Facharztprüfung Neurologie (1000 questions to prepare medical board examination in neurology)
Jan 1, 2007Thieme
Putzki Norman
CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis
Kumar M, Kreuzfelder E, Hardt C, Mueller N, Knop D, Lindemann M, Remus R, Limmroth V, Putzki N, Grosse-Wilde H. CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis. Journal of neuroimmunology 2006; 180:178-84.
Nov 1, 2006CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis
Nov 1, 2006Journal of neuroimmunology 2006; 180:178-84
Kumar Manoj, Kreuzfelder Ernst, Hardt Cornelia, Mueller Norbert, Knop Dietmar, Lindemann Monika, Remus Ralph, Limmroth Volker, Putzki Norman, Grosse-Wilde Hans
Secondary myelodysplastic syndrome following long-term treatment with azathioprine in patients with multiple sclerosis
Putzki N, Knipp S, Ramczykowski T, Vago S, Germing U, Diener H, Limmroth V. Secondary myelodysplastic syndrome following long-term treatment with azathioprine in patients with multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) 2006; 12:363-6.
Jun 1, 2006Secondary myelodysplastic syndrome following long-term treatment with azathioprine in patients with multiple sclerosis
Jun 1, 2006Multiple sclerosis (Houndmills, Basingstoke, England) 2006; 12:363-6
Putzki Norman, Knipp Sabine, Ramczykowski Tim, Vago Susanne, Germing Ulrich, Diener H Chr, Limmroth Volker
Kinesthesia is impaired in focal dystonia
Putzki N, Stude P, Konczak J, Graf K, Diener H, Maschke M. Kinesthesia is impaired in focal dystonia. Movement disorders : official journal of the Movement Disorder Society 2006; 21:754-60.
Jun 1, 2006Kinesthesia is impaired in focal dystonia
Jun 1, 2006Movement disorders : official journal of the Movement Disorder Society 2006; 21:754-60
Putzki Norman, Stude Philipp, Konczak Jürgen, Graf Karoline, Diener Hans-Christoph, Maschke Matthias